- Home
- AZZ vs SLNO Comparison
AZZ vs SLNO Comparison
Compare AZZ & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AZZ
- SLNO
- Stock Information
- Founded
- AZZ 1956
- SLNO 1999
- Country
- AZZ United States
- SLNO United States
- Employees
- AZZ N/A
- SLNO N/A
- Industry
- AZZ Industrial Specialties
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- AZZ Industrials
- SLNO Health Care
- Exchange
- AZZ Nasdaq
- SLNO Nasdaq
- Market Cap
- AZZ 3.5B
- SLNO 3.8B
- IPO Year
- AZZ N/A
- SLNO 2014
- Fundamental
- Price
- AZZ $115.23
- SLNO $51.17
- Analyst Decision
- AZZ Buy
- SLNO Strong Buy
- Analyst Count
- AZZ 6
- SLNO 10
- Target Price
- AZZ $109.67
- SLNO $112.50
- AVG Volume (30 Days)
- AZZ 195.6K
- SLNO 1.7M
- Earning Date
- AZZ 10-08-2025
- SLNO 11-05-2025
- Dividend Yield
- AZZ 0.58%
- SLNO N/A
- EPS Growth
- AZZ 908.98
- SLNO N/A
- EPS
- AZZ 8.62
- SLNO N/A
- Revenue
- AZZ $1,586,498,000.00
- SLNO $32,656,999.00
- Revenue This Year
- AZZ $6.99
- SLNO N/A
- Revenue Next Year
- AZZ $4.09
- SLNO $175.39
- P/E Ratio
- AZZ $13.49
- SLNO N/A
- Revenue Growth
- AZZ 1.70
- SLNO N/A
- 52 Week Low
- AZZ $70.90
- SLNO $41.50
- 52 Week High
- AZZ $119.95
- SLNO $90.32
- Technical
- Relative Strength Index (RSI)
- AZZ 53.27
- SLNO 23.27
- Support Level
- AZZ $112.48
- SLNO $50.63
- Resistance Level
- AZZ $119.95
- SLNO $72.99
- Average True Range (ATR)
- AZZ 2.76
- SLNO 4.38
- MACD
- AZZ -0.14
- SLNO -1.38
- Stochastic Oscillator
- AZZ 50.00
- SLNO 2.42
About AZZ AZZ Inc.
AZZ Inc is a provider of galvanizing and a variety of metal coating solutions and coil coating solutions to a broad range of end markets in North America. The company's operating segment consists of Metal Coatings, Precoat Metals, and Infrastructure Solutions. The company generates the majority of its revenue from the Precoat Metals segment, which provides coil coating application of protective and decorative coatings and related value-added downstream processing for steel and aluminum coils. Geographically, the company generates the majority of its revenue from the United States.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.